Jamaludin Zainol
Research Subjects
Jamaludin Zainol has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Taha Khalaf
Basic Medical College, Chengdu University, Chengdu 610106, China
5 shared publications - Samiah Yasmin Abdul Kadir
Faculty of Medicine, Widad University College, BIM Point, Bandar Indera Mahkota, Kuantan 25200, Malaysia
5 shared publications - Yuanyuan Wei
Basic Medical College, Chengdu University, Chengdu 610106, China
4 shared publications - Zahraa Oglah
School of Science, Auckland University of Technology (AUT), 55 Wellesley Street, Auckland 1010, New Zealand
3 shared publications - Jun Wan
Clinical Medical College, Affiliated Hospital of Chengdu University, Basic Medical College of Chengdu University, Chengdu 610106, China
2 shared publications - Ahmed Abdalla
Faculty of Electronic Information Engineering, Huaiyin Institute of Technology, Huai’an, China
1 shared publication
Latest Publications
- 29 April 2023
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 196 (1) , 261-274
Vector-Mediated Cancer Gene Therapy Reduces Toxicity and Inhibition of Lung Carcinoma Growth in Nude Mice
Replication-competent oncolytic adenovirus (TOA2) gene therapy is a recently introduced anti-tumor treatment regimen with superior results. The biodistribution studies of virus vector-based medicine seem more cautious and have been given much attention recently in terms of its quality and safety in preclinical trials. The current study determined the biodistribution and safety of a replication-competent adenovirus in different organs to predict its toxicity threshold. The present study has used TOA2, while biodistribution analysis was performed in human lung carcinoma A549-induced tumor-bearing nude mice model. Intratumoral injection was applied onto tumor-bearing mice with the adenovirus (3×1010 VP per mouse). Mice were sacrificed at the end of the experiment and the organs were dissected. Biodistribution analysis was done with complete hexon gene detection in each organ using quantitative real-time polymerase chain reaction (qRT-PCR). The biodistribution and concentration profiles showed that the TOA2 is well distributed in the entire tumor tissue. After dose 3 at day 11, the concentration of the virus has increased in the tumor tissue from 2240.54 (± 01.69) copies/100 ng genome to 13,120.28 (± 88.21) copies/100 ng genome on the 18th day, which eventually approached 336.45 (± 23.41) copies/100ng genome on the day 36. On the contrary, the concentration of the same decreased in the order of the liver, kidney, spleen, lung, and heart over time but no distributional traces in gonads. But the concentration found decreased dramatically in blood and other organs, while at the end of the experiment no detectable distribution was seen besides tumor tissue. The study confirms that adenovirus-based tumor therapy using conditionally replicating competent oncolytic TOA2 exhibited great efficiency with no toxicity at all.
- 29 April 2023
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 196 (1) , 261-274
Vector-Mediated Cancer Gene Therapy Reduces Toxicity and Inhibition of Lung Carcinoma Growth in Nude Mice
Replication-competent oncolytic adenovirus (TOA2) gene therapy is a recently introduced anti-tumor treatment regimen with superior results. The biodistribution studies of virus vector-based medicine seem more cautious and have been given much attention recently in terms of its quality and safety in preclinical trials. The current study determined the biodistribution and safety of a replication-competent adenovirus in different organs to predict its toxicity threshold. The present study has used TOA2, while biodistribution analysis was performed in human lung carcinoma A549-induced tumor-bearing nude mice model. Intratumoral injection was applied onto tumor-bearing mice with the adenovirus (3×1010 VP per mouse). Mice were sacrificed at the end of the experiment and the organs were dissected. Biodistribution analysis was done with complete hexon gene detection in each organ using quantitative real-time polymerase chain reaction (qRT-PCR). The biodistribution and concentration profiles showed that the TOA2 is well distributed in the entire tumor tissue. After dose 3 at day 11, the concentration of the virus has increased in the tumor tissue from 2240.54 (± 01.69) copies/100 ng genome to 13,120.28 (± 88.21) copies/100 ng genome on the 18th day, which eventually approached 336.45 (± 23.41) copies/100ng genome on the day 36. On the contrary, the concentration of the same decreased in the order of the liver, kidney, spleen, lung, and heart over time but no distributional traces in gonads. But the concentration found decreased dramatically in blood and other organs, while at the end of the experiment no detectable distribution was seen besides tumor tissue. The study confirms that adenovirus-based tumor therapy using conditionally replicating competent oncolytic TOA2 exhibited great efficiency with no toxicity at all.
- Open Access
- 13 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1164
The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
Integral membrane proteins, known as Transient Receptor Potential (TRP) channels, are cellular sensors for various physical and chemical stimuli in the nervous system, respiratory airways, colon, pancreas, bladder, skin, cardiovascular system, and eyes. TRP channels with nine subfamilies are classified by sequence similarity, resulting in this superfamily’s tremendous physiological functional diversity. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and aggressive form of pancreatic cancer. Moreover, the development of effective treatment methods for pancreatic cancer has been hindered by the lack of understanding of the pathogenesis, partly due to the difficulty in studying human tissue samples. However, scientific research on this topic has witnessed steady development in the past few years in understanding the molecular mechanisms that underlie TRP channel disturbance. This brief review summarizes current knowledge of the molecular role of TRP channels in the development and progression of pancreatic ductal carcinoma to identify potential therapeutic interventions.
- 13 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1164
Open AccessThe Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
Integral membrane proteins, known as Transient Receptor Potential (TRP) channels, are cellular sensors for various physical and chemical stimuli in the nervous system, respiratory airways, colon, pancreas, bladder, skin, cardiovascular system, and eyes. TRP channels with nine subfamilies are classified by sequence similarity, resulting in this superfamily’s tremendous physiological functional diversity. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and aggressive form of pancreatic cancer. Moreover, the development of effective treatment methods for pancreatic cancer has been hindered by the lack of understanding of the pathogenesis, partly due to the difficulty in studying human tissue samples. However, scientific research on this topic has witnessed steady development in the past few years in understanding the molecular mechanisms that underlie TRP channel disturbance. This brief review summarizes current knowledge of the molecular role of TRP channels in the development and progression of pancreatic ductal carcinoma to identify potential therapeutic interventions.
- Open Access
- 8 March 2023
- Published by MDPI AG in Medical Sciences Forum
- Vol. 21 (1) , 9
TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
Integral membrane proteins, known as Transient Receptor Potential (TRP), channels are cellular sensors for various physical and chemical stimuli in the nervous system, respiratory airways, colon, pancreas, bladder, skin, cardiovascular system, and eyes. TRP channels with nine subfamilies are classified by sequence similarity, resulting in this superfamily’s tremendous physiological functional diversity. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and aggressive form of pancreatic cancer. Moreover, the development of effective treatment methods for pancreatic cancer has been hindered by the lack of understanding of the pathogenesis, partly due to the difficulty in studying human tissue samples. However, scientific research on this topic has witnessed steady development in the past few years in understanding the molecular mechanisms that underlie TRP channel disturbance. This brief review summarizes current knowledge of the molecular role of TRP channels in the development and progression of pancreatic ductal carcinoma to identify potential therapeutic interventions.
- 8 March 2023
- Published by MDPI AG in Medical Sciences Forum
- Vol. 21 (1) , 9
Open AccessTRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
Integral membrane proteins, known as Transient Receptor Potential (TRP), channels are cellular sensors for various physical and chemical stimuli in the nervous system, respiratory airways, colon, pancreas, bladder, skin, cardiovascular system, and eyes. TRP channels with nine subfamilies are classified by sequence similarity, resulting in this superfamily’s tremendous physiological functional diversity. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and aggressive form of pancreatic cancer. Moreover, the development of effective treatment methods for pancreatic cancer has been hindered by the lack of understanding of the pathogenesis, partly due to the difficulty in studying human tissue samples. However, scientific research on this topic has witnessed steady development in the past few years in understanding the molecular mechanisms that underlie TRP channel disturbance. This brief review summarizes current knowledge of the molecular role of TRP channels in the development and progression of pancreatic ductal carcinoma to identify potential therapeutic interventions.
- Open Access
- 4 January 2023
- Published by MDPI AG in Sustainability
- Vol. 15 (2) , 892
How Did the Pandemic Affect Our Perception of Sustainability? Enlightening the Major Positive Impact on Health and the Environment
Since the World Health Organization (WHO) declared the outbreak of severe acute respiratory syndrome COVID-19 virus 2 (COVID-19) virus disease 2 (SARS-CoV-2) on 9 January 2020, the entire world has been exceptionally interested in examining the impact of this pandemic on people and the environment. The pandemic led to unprecedented measures to halt air traffic and close factories due to lockdowns, economic closures, and the stopping of transportation of all kinds. The decline in the use of coal by power plants, oil refining, and steel manufacturing had a beneficial effect on air pollution and caused a decrease in carbon dioxide emissions. Moreover, the concept of sustainability has become more prevalent, reflecting the increasing awareness of the responsibility placed on every member of society. Sustainability is the quality and quantity of change that meets our needs without destroying the giving planet, which is the hope for the survival of future generations. We summarized and discussed the studies and research documenting these effects on the environment and health worldwide to come up with objective conclusions, and to draw some recommendations and concepts about the importance of sustainability. The significance of this article lies in that it aims to briefly review some of the positive and negative impacts observed and reported during the SARS-CoV-2 pandemic on health and the planet’s environment for the duration of April 2020–October 2022, and finally discuss the challenges and prospects to endorse planet sustainability. While COVID-19 had many beneficial effects on the planet’s recovery, there were also profound effects on health due to the disease itself. Government and policymakers must take measures to prevent this environmental healing process from being transient.
- 4 January 2023
- Published by MDPI AG in Sustainability
- Vol. 15 (2) , 892
Open AccessHow Did the Pandemic Affect Our Perception of Sustainability? Enlightening the Major Positive Impact on Health and the Environment
Since the World Health Organization (WHO) declared the outbreak of severe acute respiratory syndrome COVID-19 virus 2 (COVID-19) virus disease 2 (SARS-CoV-2) on 9 January 2020, the entire world has been exceptionally interested in examining the impact of this pandemic on people and the environment. The pandemic led to unprecedented measures to halt air traffic and close factories due to lockdowns, economic closures, and the stopping of transportation of all kinds. The decline in the use of coal by power plants, oil refining, and steel manufacturing had a beneficial effect on air pollution and caused a decrease in carbon dioxide emissions. Moreover, the concept of sustainability has become more prevalent, reflecting the increasing awareness of the responsibility placed on every member of society. Sustainability is the quality and quantity of change that meets our needs without destroying the giving planet, which is the hope for the survival of future generations. We summarized and discussed the studies and research documenting these effects on the environment and health worldwide to come up with objective conclusions, and to draw some recommendations and concepts about the importance of sustainability. The significance of this article lies in that it aims to briefly review some of the positive and negative impacts observed and reported during the SARS-CoV-2 pandemic on health and the planet’s environment for the duration of April 2020–October 2022, and finally discuss the challenges and prospects to endorse planet sustainability. While COVID-19 had many beneficial effects on the planet’s recovery, there were also profound effects on health due to the disease itself. Government and policymakers must take measures to prevent this environmental healing process from being transient.
- Open Access
Bone Tissue Engineering through 3D Bioprinting of Bioceramic Scaffolds: A Review and Update
Trauma and bone loss from infections, tumors, and congenital diseases make bone repair and regeneration the greatest challenges in orthopedic, craniofacial, and plastic surgeries. The shortage of donors, intrinsic limitations, and complications in transplantation have led to more focus and interest in regenerative medicine. Structures that closely mimic bone tissue can be produced by this unique technology. The steady development of three-dimensional (3D)-printed bone tissue engineering scaffold therapy has played an important role in achieving the desired goal. Bioceramic scaffolds are widely studied and appear to be the most promising solution. In addition, 3D printing technology can simulate mechanical and biological surface properties and print with high precision complex internal and external structures to match their functional properties. Inkjet, extrusion, and light-based 3D printing are among the rapidly advancing bone bioprinting technologies. Furthermore, stem cell therapy has recently shown an important role in this field, although large tissue defects are difficult to fill by injection alone. The combination of 3D-printed bone tissue engineering scaffolds with stem cells has shown very promising results. Therefore, biocompatible artificial tissue engineering with living cells is the key element required for clinical applications where there is a high demand for bone defect repair. Furthermore, the emergence of various advanced manufacturing technologies has made the form of biomaterials and their functions, composition, and structure more diversified, and manifold. The importance of this article lies in that it aims to briefly review the main principles and characteristics of the currently available methods in orthopedic bioprinting technology to prepare bioceramic scaffolds, and finally discuss the challenges and prospects for applications in this promising and vital field.
Open AccessBone Tissue Engineering through 3D Bioprinting of Bioceramic Scaffolds: A Review and Update
Trauma and bone loss from infections, tumors, and congenital diseases make bone repair and regeneration the greatest challenges in orthopedic, craniofacial, and plastic surgeries. The shortage of donors, intrinsic limitations, and complications in transplantation have led to more focus and interest in regenerative medicine. Structures that closely mimic bone tissue can be produced by this unique technology. The steady development of three-dimensional (3D)-printed bone tissue engineering scaffold therapy has played an important role in achieving the desired goal. Bioceramic scaffolds are widely studied and appear to be the most promising solution. In addition, 3D printing technology can simulate mechanical and biological surface properties and print with high precision complex internal and external structures to match their functional properties. Inkjet, extrusion, and light-based 3D printing are among the rapidly advancing bone bioprinting technologies. Furthermore, stem cell therapy has recently shown an important role in this field, although large tissue defects are difficult to fill by injection alone. The combination of 3D-printed bone tissue engineering scaffolds with stem cells has shown very promising results. Therefore, biocompatible artificial tissue engineering with living cells is the key element required for clinical applications where there is a high demand for bone defect repair. Furthermore, the emergence of various advanced manufacturing technologies has made the form of biomaterials and their functions, composition, and structure more diversified, and manifold. The importance of this article lies in that it aims to briefly review the main principles and characteristics of the currently available methods in orthopedic bioprinting technology to prepare bioceramic scaffolds, and finally discuss the challenges and prospects for applications in this promising and vital field.